A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
Clinical trial NCT01148225 · COMPLETED
Trial details
- NCT number
- NCT01148225
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-23
- Primary completion
- 2018-05-21
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.